Graft-Versus-Solid-Tumor Effect: From Hematopoietic Stem Cell Transplantation to Adoptive Cell Therapies.
Barisic S, Childs RW.
Stem Cells. 2022 Jun 22;40(6):556-563. doi: 10.1093/stmcls/sxac021.
Graft versus tumor effects and why people relapse.
Falkenburg JHF, Jedema I.
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):693-698. doi: 10.1182/asheducation-2017.1.693.
Recipient and donor cells in the graft-versus-solid tumor effect: It takes two to tango.
Dierckx de Casterlé I, Billiau AD, Sprangers B.
Blood Rev. 2018 Nov;32(6):449-456. doi: 10.1016/j.blre.2018.04.002. Epub 2018 Apr 12.
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.
Gyurkocza B, Sandmaier BM.
Blood. 2014 Jul 17;124(3):344-53. doi: 10.1182/blood-2014-02-514778. Epub 2014 Jun 9.
Oral graft-versus-host disease.
Kuten-Shorrer M, Woo SB, Treister NS.
Dent Clin North Am. 2014 Apr;58(2):351-68. doi: 10.1016/j.cden.2013.12.007.
Graft-versus-cancereffect and innovative approaches in thetreatment of refractory solid tumors.
Şahin U, Demirer T.
Turk J Med Sci. 2020 Nov 3;50(SI-2):1697-1706. doi: 10.3906/sag-1911-112.
The allogeneic graft-versus-cancer effect.
Ringdén O, Karlsson H, Olsson R, Omazic B, Uhlin M.
Br J Haematol. 2009 Dec;147(5):614-33. doi: 10.1111/j.1365-2141.2009.07886.x. Epub 2009 Sep 4.
Reduced-intensity hematopoietic stem cell transplants for malignancies: harnessing the graft-versus-tumor effect.
Gill S, Porter DL.
Annu Rev Med. 2013;64:101-17. doi: 10.1146/annurev-med-121411-103452. Epub 2012 Oct 29.
T cell receptor gene-modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft-versus-host disease.
Okada S, Muraoka D, Yasui K, Tawara I, Kawamura A, Okamoto S, Mineno J, Seo N, Shiku H, Eguchi S, Ikeda H.
Cancer Sci. 2023 Nov;114(11):4172-4183. doi: 10.1111/cas.15954. Epub 2023 Sep 7.
Granulocyte-macrophage colony stimulating factor in autologous bone marrow transplantation: augmentation of graft versus tumor effect via antibody dependent cellular cytotoxicity.
Charak BS, Sadowski RM, Mazumder A.
Leuk Lymphoma. 1993 Apr;9(6):453-7. doi: 10.3109/10428199309145752.
